Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial - Neoptolemos, John P.; Hackert, Thilo; Büchler, Markus W. (The lancet, 2017)
Available online 25 January 2017